László Őrfi

High-Affinity Interaction of Tyrosine Kinase Inhibitors with the ABCG2 Multidrug Transporter

Csilla Özvegy‐Laczka, Tamás Hegedűs, György Várady et al. · Molecular Pharmacology · 2004 · 340 citations · Full text

Medicine, Cancer Biology, Pharmacology +17

Flk-1 as a target for tumor growth inhibition.

L M Strawn, Gerald McMahon, Harald App et al. · PubMed · 1996 · 318 citations

Medicine, Oncology, Pharmacology +15

Interaction of nilotinib, dasatinib and bosutinib with ABCB1 and ABCG2: implications for altered anti‐cancer effects and pharmacological properties

C. Hegedüs, Csilla Özvegy‐Laczka, Ágota Apáti et al. · British Journal of Pharmacology · 2009 · 227 citations · Full text

Medicine, Oncology, Pharmacology +15

AXL Is a Potential Target for Therapeutic Intervention in Breast Cancer Progression

Yi-xiang Zhang, Peter G. Knyazev, Yu. V. Cheburkin et al. · Cancer Research · 2008 · 210 citations

Life Sciences, Cell Biology, Oncology +17

Small Molecule Inhibition of ERK Dimerization Prevents Tumorigenesis by RAS-ERK Pathway Oncogenes

Ana Herrero, Adán Pinto, Paula Colón‐Bolea et al. · Cancer Cell · 2015 · 151 citations

Medicine, Molecular Biology, Oncology +16